Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats (Q43297014)

18 November 2017

title

Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats (English)

1 reference

18 November 2017

1

Shinji Takai

1 reference

18 November 2017

2

Denan Jin

1 reference

18 November 2017

Hironobu Ikeda

3

1 reference

18 November 2017

Hiroshi Sakonjo

series ordinal

4

1 reference

18 November 2017

Mizuo Miyazaki

series ordinal

5

1 reference

18 November 2017

publication date

7 August 2009

1 reference

18 November 2017

published in

Hypertension Research

1 reference

18 November 2017

volume

32

1 reference

18 November 2017

issue

10

1 reference

18 November 2017

page(s)

853-860

1 reference

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Beneficial effect of trandolapril on the lifespan of a severe hypertensive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

The regressive effect of an angiotensin II receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

inferred from DOI database lookup

7 January 2021

based on heuristic

Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

inferred from DOI database lookup

7 January 2021

based on heuristic

Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.116

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/HR.2009.116

1 reference

18 November 2017

1 reference